MedTrace Logo

Prospective Catalystem CT-RSA

NCT07698717 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-07-13

No results posted yet for this study

Summary

Multi-Centre Study in patients undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The primary objective is to establish the mean inferior stem migration (subsidence) of the CATALYSTEM™ stem using CT-RSA over the first two postoperative years.

Conditions

  • Hip Osteoarthritis

Interventions

DEVICE

CATALYSTEM

CATALYSTEM Cementless Primary Hip System for participants with Total Hip Arthroplasty

Sponsors & Collaborators

  • Canadian Radiostereometric Analysis Network

    lead OTHER

Principal Investigators

  • Thomas Turgeon, MD · University of Manitoba

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07698717 on ClinicalTrials.gov